Biopharma organizations generate unprecedented volumes of data, driven by accelerated timelines, evolving regulatory expectations, and increasing demand for continuous evidence. Yet more data hasn’t translated into clearer direction. At BGBx, we transform complex data into focused narratives and engagement strategies, so the right information drives clarity when decisions are actually made.
Medical affairs and peer-to-peer engagement share a common purpose: shaping how evidence is understood and applied in practice. At BGBx, we connect these disciplines through a coordinated approach that aligns evidence, scientific narrative, stakeholder strategy, and engagement so information is not only delivered, but understood, trusted, and applied where it matters most.
Biopharma organizations generate unprecedented volumes of data, driven by accelerated timelines, evolving regulatory expectations, and increasing demand for continuous evidence. Yet more data hasn’t translated into clearer direction. At BGBx, we transform complex data into focused narratives and engagement strategies, so the right information drives clarity when decisions are actually made.
Medical affairs and peer-to-peer engagement share a common purpose: shaping how evidence is understood and applied in practice. At BGBx, we connect these disciplines through a coordinated approach that aligns evidence, scientific narrative, stakeholder strategy, and engagement so information is not only delivered, but understood, trusted, and applied where it matters most.
Evaluate clinical data, competitive intelligence, and unmet need to establish a clear, differentiated position grounded in how therapies are evaluated in practice—and validated through scenario testing.
Combine advanced data with deep, long-standing HCP relationships to map, segment, and activate opinion leaders, through steering committees, advisory boards and asynchronous engagement.
Build scientific platforms, core story architecture, and lexicon that cut through data complexity and define how your therapy is understood—validated against how stakeholders interpret and act on evidence in real-world clinical practice.
Identify evidence gaps, guide integrated evidence generation planning, and align data, publications, and communication to support differentiation, adoption, and access across the asset lifecycle.
Provide training, scientific resources, and MSL tools that support effective engagement, aligned within regulatory and organizational constraints—where clarity directly impacts engagement.
Deliver integrated, omnichannel engagement across congresses, digital, live and on-demand content to deliver measurable behavior change, connecting scientific exchange, speaker-led engagement, digital platforms, and MSL interactions aligned to how adoption happens in practice.
Develop peer-to-peer product and portfolio strategies aligned to how HCPs evaluate and prescribe in the real world.
Combine advanced data with deep, long-standing relationships to map, segment, and activate opinion leaders, advisory networks, and expert communities—generating insight and extending education through speaker engagement.
Build the narrative to differentiate your therapy and define how it’s understood across the customer journey—pressure-tested against how clinical decision-makers interpret and act on data in real-world clinical practice.
Develop leave-behinds, objection handlers, MOA and clinical data narratives, training modules, and reference decks that enable a consistent on label story—MLR-ready, brand-aligned, and built to hold up in the moments that move prescribing behavior.
Extend influence across channels and through peer-to-peer activation, congresses and symposia both in person and asynchronously. Activate integrated, omnichannel delivery pre- and post-engagements to cultivate HCP advocates and extend your sphere of influence.
See how BGBx established a record-high pre-launch
awareness through aligned, consistent scientific communication.
Shape clinical decision-making with evidence that is clear, credible, and actionable.
Establish a differentiated scientific narrative that holds across stakeholders and touchpoints.
Identify and activate the right experts and networks based on true influence in practice.
Scale medical education through omnichannel engagement aligned to how decisions are made.
Build sustained engagement that evolves from consultation to long-term partnership.
Shape clinical decision-making with evidence that is clear, credible, and actionable.
Establish a differentiated scientific narrative that holds across stakeholders and touchpoints.
Identify and activate the right experts and networks based on true influence in practice.
Scale medical education through omnichannel engagement aligned to how decisions are made.
Build sustained engagement that evolves from consultation to long-term partnership.
BGBx’s medical communications approach is built on the Breakthrough Process, powered by 3D Science—integrating medical, data, and behavioral expertise to align evidence, scientific narrative, and engagement across Medical Affairs and Promotional Medical Education.
We combine data-driven insight with more than 20 years of experience across oncology, neurology, cardiovascular disease, immunology and inflammation, metabolic disorders, and rare disease—along with deep, long-standing HCP relationships. This enables us to identify, prioritize, and engage the right experts and networks, so engagement reflects real-world clinical dynamics, not just traditional metrics.
Medical communications span both Medical Affairs and Promotional Medical Education, translating clinical, mechanistic, and real-world evidence into scientific narratives that shape how healthcare providers interpret data and make treatment decisions. At BGBx, it is designed to build scientific influence, so evidence is not only communicated, but understood, trusted, and applied in real-world practice.
At BGBx, we identify and engage the right experts by mapping and integrating data across the full scientific and clinical ecosystem to prioritize and validate key opinion leaders, emerging voices, and multidisciplinary networks based on real-world influence.
We combine scientific, clinical, and digital data with deep, long-standing relationships and experience to understand how experts contribute across the patient journey, then engage them at the right moments to support strategy, consultation, and real-world adoption.
BGBx brings together deep data insight, long-standing HCP relationships, and scientific expertise to align evidence, narrative, and engagement—so the right information is understood, trusted, and applied in real-world decisions when it matters most.
Copyright © 2026 BGB Group. All rights reserved.
Pages
Social
